|
Market Research Report
A Survey of Private Companies Active in Alzheimer's Drug R&D
| Published by |
Startupguys Ltd |
| Published |
March, 2006 |
Product code |
37454 |
| Content info |
148 Pages |
| Price |
|
|
A Survey of Private Companies Active in Alzheimer's Drug R&D published by Startupguys Ltd in March, 2006. This report consists of 148 Pages and the price starts from US $ 730.
Abstract
This spin-off report of "A Survey of Private Companies Active in CNS & PNS
Drug R&D" comprises the private companies active in Alzheimer's R&D covered in
the full report. Launched in March 2006 the product combines an Excel company
database covering 86 companies active in Alzheimer's drug research and
development with a full cross-referenced report in PDF format describing each
company in detail. Contact details, descriptive background information,
management team, investors and CNS/PNS drug pipeline are provided for all
entries. "A Survey of Private Companies Active in Alzheimer's Drug R&D" is by
far the most comprehensive survey of private players active in the Alzheimer's
market space available to this date. It is a must have report for everyone
professionally involved in Alzheimer's drug development and Alzheimer's drug
development companies.
Table of Contents
COMPANY DIRECTORY
- Ablynx
- Accera Pharmaceuticals
- AC Immune
- Acumen Pharmaceuticals
- Addex Pharmaceuticals
- AFFiRiS
- AGY Therapeutics
- ArmaGen Technologies
- Athersys
- Axon Neuroscience
- Bicoll
- Bioarctic Neuroscience
- Brainsgate
- Capsant Neurotechnologies
- Cellzome
- Cerebricon
- Ceregene
- Chiesi Group / Chiesi Farmaceutici
- CNAssays
- Cognitive Pharmaceuticals
- Cognosci
- CoLucid Pharmaceuticals
- Daniolabs
- D-Pharm
- eNOS Pharmaceuticals
- EnVivo Pharmaceuticals
- ESBA Tech
- Ester Neurosciences
- Esteve
- FAN
- Faust Pharmaceuticals
- Helicon Therapeutics
- Howard Associates
- Hunter-Fleming
- i3 Research
- Icogenex
- Intra-Cellular Therapies
- Janssen Pharmaceutica (J&J subsidiary)
- JSW Research
- KeyNeurotek
- Kinexis
- Krenitsky Pharmaceuticals
- Medexis Biotech (Gerolymatos Subsidiary)
- Medimod Pharmacology Services
- MOTAC Neuroscience / MOTAC Cognition
- Muscagen
- Neurim Pharmaceuticals
- Neurobiomed
- Neurofit
- Neuroinvestigations
- Neurology Clinical Research
- Neurome
- Neuromolecular Pharmaceuticals
- Neuronova
- Neuropharma (Zeltia Subsidiary)
- Neuroprofile
- Neurotargets
- Neurotune
- Newneural
- NsGene (Neurosearch Spinoff)
- Nura
- Panacea Pharmaceuticals
- Pharmaxon
- Pharmidex
- Predix Pharmaceuticals
- Priosense
- Proneuron Biotechnologies
- ProteoTech
- Reata Pharmaceuticals
- reMYND
- Rinat Neuroscience
- Rottapharm Group
- Saegis Pharmaceuticals
- Senexis
- Siena Biotech
- Sigma-Tau Pharmaceuticals / Biofutura Pharma
- Somerset Pharmaceuticals
- Targacept
- The Genetics Company
- TorreyPines Therapeutics
- Trophos
- Ventana CRC
- Verne Mendel Medical
- Voyager Pharmaceuticals
- Zapaq
- Zyentia
|
